Please login to the form below

Not currently logged in
Email:
Password:

oncology

This page shows the latest oncology news and features for those working in and with pharma, biotech and healthcare.

Janssen looks to expand Darzalex in Europe

Janssen looks to expand Darzalex in Europe

It has filed the regimen with the EMA just two months after its submission to the FDA, which will quickly assess the Darzalex combination under the Real-Time Oncology Review pilot

Latest news

  • Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity

    The collaboration will use AI to accelerate the discovery of small molecule therapeutic drug candidates for three therapeutic programmes for Celgene in the areas of oncology and autoimmunity. ... platform will very favourably impact our ability to

  • Fishawack acquires Dudnyk Fishawack acquires Dudnyk

    Dudnyk brings to Fishawack a particular expertise in rare diseases, oncology, and launching breakthrough molecular medicines,” explains Christopher Tobias, President of Dudnyk. ... Companies. “The leadership at Dudnyk clearly cares about their people,

  • Roche gets FDA nod for Tecentriq in small cell lung cancer Roche gets FDA nod for Tecentriq in small cell lung cancer

    Nevertheless, the approval extends Tecentriq’s position in lung cancer as Roche tries to build momentum behind its flagship immuno-oncology drug.

  • CHMP recommends new Keytruda dosing schedule CHMP recommends new Keytruda dosing schedule

    Will apply to eight indications across five tumour types. MSD’s star oncology player Keytruda could be on track to a more flexible dosing schedule after it received a positive opinion ... It most recently gained the first immuno-oncology approval in

  • Gottlieb admonishes industry for clinical trial failings Gottlieb admonishes industry for clinical trial failings

    Earlier this week the FDA also released guidance on how they can incorporate patients with more challenging health conditions into oncology clinical trials, to make the studies more representative of real

More from news
Approximately 387 fully matching, plus 1,292 partially matching documents found.

Latest Intelligence

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    is furthering work in DNA damage response (DDR), a key platform in oncology. ... CRISPR libraries aren’t exclusively reserved for oncology, however. AstraZeneca has confirmed that it is applying the tech across other therapy areas, including

  • Immuno-oncology in 2019: the rapid evolution continues Immuno-oncology in 2019: the rapid evolution continues

    However, the company continues to study Opdivo in trials twinned with a very wide range of novel agents, with the hope of finding a combination which can take immuno-oncology (IO)

  • Immunotherapy combination trials Q&A Immunotherapy combination trials Q&A

    By Chris Learn and Martin Lachs. The immuno-oncology (IO) field is becoming incredibly crowded and competitive. ... Chris Learn is Program Manager and Martin Lachs is VP Project Management, both at Oncology Haematology, ICON plc.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    9. Vitrakvi – a novel addition to the immune-oncology market. Earlier this year Merck &Co/MSD became the first company to secure approval for a ‘tissue agnostic’ drug when its ... Merck/MSD looks to have gained a dominant position in checkpoint

  • Why precision medicine demands precision engagement Why precision medicine demands precision engagement

    Focusing on oncology, Evaluate Research estimates that more than 85% of the market is now focused on targeted therapies. ... This trend in the market is making obsolete the traditional methods used to build and maintain relationships in the oncology

More from intelligence
Approximately 18 fully matching, plus 179 partially matching documents found.

Latest appointments

More from appointments
Approximately 12 fully matching, plus 262 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 49 fully matching, plus 90 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics